INS and Insulin resistance: Mean fasting plasma insulin increased and HOMA %S (insulin sensitivity; the reciprocal of HOMA-insulin resistance) decreased within the rhGH arm but did not change significantly from baseline within the dual therapy arm, suggesting a beneficial effect of the addition of rosiglitazone on glucose homeostasis.